MORGAN STANLEY - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 41 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,706
-32.4%
15,406
-11.0%
0.00%
Q2 2023$14,364
+88.7%
17,3060.0%0.00%
Q1 2023$7,614
-25.0%
17,306
+0.6%
0.00%
Q4 2022$10,150
-43.6%
17,207
-31.4%
0.00%
Q3 2022$18,000
-50.0%
25,071
+1.3%
0.00%
Q2 2022$36,000
-62.1%
24,752
-0.8%
0.00%
Q1 2022$95,000
-62.3%
24,964
-22.6%
0.00%
Q4 2021$252,00032,2400.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
First PREMIER Bank 652,440$946,0000.28%
METEORA CAPITAL, LLC 292,538$424,0000.08%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$113,0000.02%
SILVER OAK SECURITIES, Inc 51,941$64,0000.01%
Shaolin Capital Management LLC 275,000$399,0000.01%
Elgethun Capital Management 13,296$18,0000.01%
LGL PARTNERS, LLC 23,000$33,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$122,0000.00%
Spectrum Management Group, LLC 5,030$7,0000.00%
Veritable, L.P. 43,551$63,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders